Vascular and angiogenic activities of CORM-401, an oxidant-sensitive CO-releasing molecule

Biochemical Pharmacology

Volumn 102, Issue , 2016, Pages 64-77

  Fayad Kobeissi, Sarah ^a,b   Ratovonantenaina, Johary ^a,b   Dabiré, Hubert ^b   Wilson, Jayne Louise ^a,b   Rodriguez, Anne Marie ^a,b   Berdeaux, Alain ^b   Dubois Randé, Jean Luc ^c   Mann, Brian E ^d   Motterlini, Roberto ^a,b   Foresti, Roberta ^a,b  

^a FACULTÉ DE MÉDECINE   (France)

^b INSERM U955   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Angiogenesis; Carbon monoxide; Carbon monoxide releasing molecules; Heme oxygenase 1; p38 MAPK; Vascular activity

Indexed keywords

ANGIOGENIC FACTOR; ANTIINFLAMMATORY AGENT; CARBON MONOXIDE; CORM 401; HEME OXYGENASE 1; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; INTERLEUKIN 8; MANGANESE; MITOGEN ACTIVATED PROTEIN KINASE P38; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; OXIDIZING AGENT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL TONE; CELL MIGRATION; CONTROLLED STUDY; DRUG DESIGN; DRUG MECHANISM; DRUG SYNTHESIS; ENDOTHELIUM CELL; EX VIVO STUDY; HALF LIFE TIME; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; VASODILATATION; AGONISTS; ANIMAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; HUMAN; MALE; METABOLISM; SECRETION (PROCESS); THORACIC AORTA; TUMOR CELL LINE; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; AORTA, THORACIC; CARBON MONOXIDE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; MALE; OXIDANTS; RATS; RATS, WISTAR;

EID: 84958745513     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2015.12.014     Document Type: Article

References (41)

1. P.R. Ortiz de Montellano The mechanism of heme oxygenase Curr. Opin. Chem. Biol. 4 2000 221 227
2. S.W. Ryter, J. Alam, and A.M. Choi Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications Physiol. Rev. 86 2006 583 650
3. R. Motterlini, and L.E. Otterbein The therapeutic potential of carbon monoxide Nat. Rev. Drug Discov. 9 2010 728 743
4. R. Motterlini, J.E. Clark, R. Foresti, P. Sarathchandra, B.E. Mann, and C.J. Green Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities Circ. Res. 90 2002 e17 e24
5. J.E. Clark, P. Naughton, S. Shurey, C.J. Green, T.R. Johnson, B.E. Mann, and et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule Circ. Res. 93 2003 e2 e8
6. R. Motterlini, P. Sawle, S. Bains, J. Hammad, R. Alberto, R. Foresti, and et al. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule FASEB J. 19 2005 284 286
7. Y. Guo, A.B. Stein, W.J. Wu, W. Tan, X. Zhu, Q.H. Li, and et al. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo Am. J. Physiol Heart Circ. Physiol. 286 2004 H1649 H1653
8. A. Sandouka, B.J. Fuller, B.E. Mann, C.J. Green, R. Foresti, and R. Motterlini Treatment with carbon monoxide-releasing molecules (CO-RMs) during cold storage improves renal function at reperfusion Kidney Int. 69 2006 239 247
9. M.L. Ferrandiz, N. Maicas, I. Garcia-Arnandis, M.C. Terencio, R. Motterlini, I. Devesa, and et al. Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis Ann. Rheum. Dis. 67 2008 1211 1217
10. O. De Backer, E. Elinck, B. Blanckaert, L. Leybaert, R. Motterlini, and R.A. Lefebvre Water-soluble CO-releasing molecules (CO-RMs) reduce the development of postoperative ileus via modulation of MAPK/HO-1 signaling and reduction of oxidative stress Gut 58 2009 347 356
11. M. Desmard, K.S. Davidge, O. Bouvet, D. Morin, D. Roux, R. Foresti, and et al. A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia FASEB J. 23 2009 1023 1031
12. M. Desmard, R. Foresti, D. Morin, M. Dagoussat, A. Berdeaux, E. Denamur, and et al. Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules Antioxid. Redox Signal. 16 2012 153 163
13. B.E. Mann CO-releasing molecules: a personal view Organometallics 31 2012 5728 5735
14. U. Schatzschneider Novel lead structures and activation mechanisms for CO-releasing molecules (CORMs) Br. J. Pharmacol. 172 2014 1638 1650
15. H. Inaba, K. Fujita, and T. Ueno Design of biomaterials for intracellular delivery of carbon monoxide Biomater. Sci. 13 2015 1423 1438
16. R. Motterlini, B.E. Mann, and R. Foresti Therapeutic applications of carbon monoxide-releasing molecules (CO-RMs) Expert Opin. Investig. Drugs 14 2005 1305 1318
17. P. Wang, H. Liu, Q. Zhao, Y. Chen, B. Liu, B. Zhang, and et al. Syntheses and evaluation of drug-like properties of CO-releasing molecules containing ruthenium and group 6 metal Eur. J. Med. Chem. 74 2014 199 215
18. 2H)}], a new water-soluble CO-releasing molecule Dalton Trans. 40 2011 4230 4235
19. R. Motterlini, A. Gonzales, R. Foresti, J.E. Clark, C.J. Green, and R.M. Winslow Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo Circ. Res. 83 1998 568 577
20. I.A. Sammut, R. Foresti, J.E. Clark, D.J. Exon, M.J.J. Vesely, P. Sarathchandra, and et al. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1 Br. J. Pharmacol. 125 1998 1437 1444
21. R. Foresti, J. Hammad, J.E. Clark, R.A. Johnson, B.E. Mann, A. Friebe, and et al. Vasoactive properties of CO RM-3, a novel water-soluble carbon monoxide-releasing molecule Br. J. Pharmacol. 142 2004 453 460
22. A. Zimmermann, C.W. Leffler, D. Tcheranova, A.L. Fedinec, and H. Parfenova Cerebroprotective effects of the CO-releasing molecule CORM-A1, against seizure-induced neonatal vascular injury Am. J. Physiol. Heart Circ. Physiol 293 2007 H2501 H2507
23. A. Jozkowicz, I. Huk, A. Nigisch, G. Weigel, W. Dietrich, R. Motterlini, and et al. Heme oxygenase-1 and angiogenic activity of endothelial cells: stimulation by carbon monoxide inhibition by tin protoporphyrin IX Antioxid. Redox Signal. 5 2003 155 162
24. J. Dulak, J. Deshane, A. Jozkowicz, and A. Agarwal Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis Circulation 117 2008 231 241
25. J. Deshane, S. Chen, S. Caballero, A. Grochot-Przeczek, H. Was, C.S. Li, and et al. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism J. Exp. Med. 204 2007 605 618
26. B.W. Michel, A.R. Lippert, and C.J. Chang A reaction-based fluorescent probe for selective imaging of carbon monoxide in living cells using a palladium-mediated carbonylation J. Am. Chem. Soc. 134 2012 15668 15671
27. A.J. Atkin, J.M. Lynam, B.E. Moulton, P. Sawle, R. Motterlini, N.M. Boyle, and et al. Modification of the deoxy-myoglobin/carbonmonoxy-myoglobin UV-vis assay for reliable determination of CO-release rates from organometallic carbonyl complexes Dalton Trans. 40 2011 5755 5761
28. J.L. Wilson, S. Fayad Kobeissi, S. Oudir, B. Haas, B.W. Michel, J.L. Dubois-Rande, and et al. Design and synthesis of novel hybrid molecules that activate the transcription factor Nrf2 and simultaneously release carbon monoxide Chemistry 20 2014 14698 14704
29. M. Feletou, and P.M. Vanhoutte Endothelium-dependent hyperpolarizations: past beliefs and present facts Ann. Med. 39 2007 495 516
30. J.D. Hayes, and A.T. Dinkova-Kostova The Nrf2 regulatory network provides an interface between redox and intermediary metabolism Trends Biochem. Sci. 39 2014 199 218
31. J. Dulak, A. Jozkowicz, R. Foresti, A. Kasza, M. Frick, I. Huk, and et al. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells Antioxid. Redox Signal. 4 2002 229 240
32. L.E. Otterbein, F.H. Bach, J. Alam, M. Soares, H. Tao Lu, M. Wysk, and et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway Nat. Med. 6 2000 422 428
33. A. Cuenda, and S. Rousseau p38 MA P-kinases pathway regulation, function and role in human diseases Biochim. Biophys. Acta 1773 2007 1358 1375
34. 2 generation: redox signaling and oxidative stress J. Biol. Chem. 289 2014 8735 8741
35. U. Florczyk, A. Jazwa, M. Maleszewska, M. Mendel, K. Szade, M. Kozakowska, and et al. Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia Antioxid. Redox Signal. 20 2014 1693 1708
36. L. Kuang, J. Feng, G. He, and T. Jing Knockdown of Nrf2 inhibits the angiogenesis of rat cardiac micro-vascular endothelial cells under hypoxic conditions Int. J. Biol. Sci. 9 2013 656 665
37. P.L. Chi, C.C. Lin, Y.W. Chen, L.D. Hsiao, and C.M. Yang CO induces Nrf2-dependent heme oxygenase-1 transcription by cooperating with Sp1 and c-Jun in rat brain astrocytes Mol. Neurobiol. 52 2015 277 292
38. H.T. Chung, S.K. Kim, Y. Joe, M. Zheng, H.J. Kim, J.K. Yu, and et al. Resveratrol induces hepatic mitochondrial biogenesis through the sequential activation of nitric oxide and carbon monoxide production Antioxid. Redox Signal. 20 2014 2589 2605
39. Y.K. Choi, C.K. Kim, H. Lee, D. Jeoung, K.S. Ha, Y.G. Kwon, and et al. Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein J. Biol. Chem. 285 2010 32116 32125
40. B.Y. Chin, G. Jiang, B. Wegiel, H.J. Wang, T. MacDonald, X.C. Zhang, and et al. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning Proc. Natl. Acad. Sci. U. S. A. 104 2007 5109 5114
41. H.H. Lin, S.C. Lai, and L.Y. Chau Heme oxygenase-1/carbon monoxide induces vascular endothelial growth factor expression via p38 kinase-dependent activation of Sp1 J. Biol. Chem. 286 2011 3829 3838